System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework

作者：Kathryn Mary Abel, Emily Agnew, James Amos, Natalie Armstrong, Darius P. H. Armstrong-James, Tom Ashfield, Stephen Aston, John Kenneth Baillie, Steve Baldwin, Gavin D Barlow, Victoria Bartle, Julia Anna Bielicki, Colin Stewart Brown, Enitan D. Carrol, Michelle Clements, Graham S. Cooke, Aaron L. Dane, Paul M Dark, Jeremy Day, Anthony De Soyza, Andrew W. Dowsey, Stephanie A. Evans, David W. Eyre, Timothy Felton, Tom Fowler, Robbie Foy, K.S. Gannon, Alessandro Gerada, Anna L. Goodman, Tracy Harman, Gail Hayward, Alison Holmes, Susan Hopkins, Philip A. Howard, Alexander Howard, Yingfen Hsia, Gwenan M. Knight, Nick Lemoine, James Koh, Alasdair P. MacGowan, Charis Marwick, Catrin E. Moore, Seamus O’Brien, Raymond Oppong, Sharon J. Peacock, Sarah Lilian Pett, Koen Bernardus Pouwels, Chris Queree, Najib Mahboob Rahman, Mark J. Sculpher, Laura J. Shallcross, Michael Sharland, Jasvinder A. Singh, Karen Stoddart, Emma Thomas‐Jones, Andrew Townsend, Andrew Ustianowski, Tjeerd Pieter van Staa, Sarah Walker, Peter J White, Paul Wilson, Iain Edward Buchan, Beth S. Woods, Peter Bower, Martin Llewelyn, William W. Hope · 发表于：The Lancet Microbe · 年份：2024 · DOI：10.1016/s2666-5247(24)00003-x · 被引用次数：18 · 研究领域：Antibiotic Use and Resistance、Complementary and Alternative Medicine Studies、Patient Satisfaction in Healthcare

Antimicrobial resistance (AMR) threatens human, animal, and environmental health. Acknowledging the urgency of addressing AMR, an opportunity exists to extend AMR action-focused research beyond the confines of an isolated biomedical paradigm. An AMR learning system, AMR-X, envisions a national network of health systems creating and applying optimal use of antimicrobials on the basis of their data collected from the delivery of routine clinical care. AMR-X integrates traditional AMR discovery, experimental research, and applied research with continuous analysis of pathogens, antimicrobial uses, and clinical outcomes that are routinely disseminated to practitioners, policy makers, patients, and the public to drive changes in practice and outcomes. AMR-X uses connected data-to-action systems to underpin an evaluation framework embedded in routine care, continuously driving implementation of improvements in patient and population health, targeting investment, and incentivising innovation. All stakeholders co-create AMR-X, protecting the public from AMR by adapting to continuously evolving AMR threats and generating the information needed for precision patient and population care.